Insider / Supernus, Inc.
Ciaffoni Joseph
Chief Executive Officer at Supernus, Inc.
- Company
- Supernus, Inc.
- Ticker
- SUPN
- First filing on record
- June 23, 2026
- Latest trade on record
- June 22, 2026
- SEC filings
- EDGAR ↗
Ciaffoni Joseph, Chief Executive Officer at Supernus, Inc., has disclosed 3 transactions in SUPN since June 23, 2026: 0 purchases (0 open-market buys) and 1 sale, worth about $23.5M at the reported prices. The latest was filed June 23, 2026, 1 day after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Ciaffoni Joseph made no purchases and 1 sale worth $23M, plus 2 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Ciaffoni Joseph has traded 1 stock on record; the largest by dollars is SUPN.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 2 | 2,533,806 | — |
| F | Shares withheld for tax | 1 | 612,549 | $23.5M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 3 | 0 | 1 · $23.5M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| SUPN | Option / conversion M | June 22, 2026 | June 23, 2026 | 1d | 1,266,903 | — | — | derivative | Form 4 ↗ | |
| SUPN | Sell F | June 22, 2026 | June 23, 2026 | 1d | 612,549 | $38 | $23.5M | Form 4 ↗ | ||
| SUPN | Option / conversion M | June 22, 2026 | June 23, 2026 | 1d | 1,266,903 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| June 23, 2026 | Form 4 | 0001443841-26-000007 | 3 | published | EDGAR ↗ |
Other insiders at Supernus, Inc.
- Bhatt Padmanabh P. Sr. VP of IP, CSO 61 rows
- Khattar Jack A. President, CEO 57 rows
- Mottola Frank SVP, Chief Tech. Ops. Officer 52 rows
- DEC TIMOTHY C Senior Vice-President & CFO 45 rows
- Rubin Jonathan SVP, Chief Medical Officer 39 rows
- Horich William Todd SVP, Commercial Operations 31 rows
- GEMAYEL GEORGES Director 22 rows
- Barlow Carrolee Director 15 rows
- Sensenig Bethany Director 11 rows
- Anderson Woodrow D Chief Accounting Officer 2 rows
Everyone on file, with contracts and lobbying under the company's name: Supernus, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 3 | June 23, 2026 | June 23, 2026 | Form 4 list on EDGAR |
Site built November 12, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.